68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery
68Ga-PSMA-11 PET/CT for Staging of Intermediate and High Risk Prostate Cancer Prior to Radical Prostatectomy
Sponsor: Jonsson Comprehensive Cancer Center
This NA trial investigates Prostate Adenocarcinoma and Stage IIB Prostate Cancer AJCC v7 and is currently completed. Jonsson Comprehensive Cancer Center leads this study, which shows 13 recorded versions since 2016 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2023 — Jul 2024 [monthly]
Completed NA
-
Sep 2021 — May 2023 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Apr 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
▶ Show 8 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Jun 2020 — Aug 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2020 — Jun 2020 [monthly]
Recruiting NA
-
Jul 2019 — Feb 2020 [monthly]
Recruiting NA
-
Mar 2019 — Jul 2019 [monthly]
Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Jonsson Comprehensive Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .